Lean Manufacturing ofPolyurethane, Assisted by Near-infrared (NIR) andRaman Spectroscopy

November 11, 2018

Chemical manufacturing such as polyurethane production is characterized by a cost-intensive production process combined with a negative ecological impact. These adverse effects can be significantly improved by using vibrational spectroscopy. This analytical technique can assist the operator of the plant to reduce costs and minimize the impact on the environment as is demonstrated in the present
white paper.

Spotlight

Primorigen Biosciences

Primorigen Biosciences' mission is to develop robust, reliable reagents and tools in support of research and clinical applications of stem cells. These include StemAdhere™ and StemAdhere XF™, a defined and/ or xenobiotic-free substrate for the maintenance and expansion of pluripotent cells.

OTHER WHITEPAPERS
news image

Advanced Treatments Gene and Cell Therapy

whitePaper | April 26, 2022

Public Policy Projects (PPP) is a global policy institute offering practical analysis and development across a range of sectors, including health and social care.

Read More
news image

Gene, Cell, & RNA Therapy Landscape

whitePaper | January 24, 2022

The American Society of Gene & Cell Therapy (ASGCT) is the primary professional membership organization.

Read More
news image

Best Practices for RIM Business Process Automation

whitePaper | December 15, 2022

Regulatory teams at life science companies are finding that effective regulatory information management (RIM) has become critical to their operations.

Read More
news image

HIGH THROUGHPUT AAV VIRAL TITERING USING NANOPLATE-BASED DIGITAL PCR

whitePaper | December 22, 2022

Determining the physical titer of viral vectors has typically been accomplished using digital droplet PCR (ddPCR). Droplet-based methods, however, are challenged by matrix effects and long analysis times (up to 7 hours).

Read More
news image

T Cell Expansion in Small Scale Bioreactors

whitePaper | October 28, 2022

Adoptive cell therapy (ACT), a branch of immunotherapy, offers a promising treatment for chronic viral infections and malignant diseases such as cancer [1]. This innovative approach involves the autologous or allogenic transplant of immune cells into the patient’s body.

Read More
news image

Healthcare system readiness for the adoption of advanced therapies: learnings from the introduction of CAR T cell therapies in the UK

whitePaper | September 17, 2021

The adoption of CAR T therapies in the UK NHS is a success story, especially seen in relation to the experience in many other countries. The UK NHS showed itself to be agile, and responsive to addressing the unique challenges these therapies present, which facilitated access to patients earlier than in many other countries. (including delivery centre selection, development of service specifications, collaboration with manufacturers throughout the preparation phase for adoption, establishment of national multidisciplinary CAR T team to ensure equity of access and prioritization of resources (where needed)).

Read More

Spotlight

Primorigen Biosciences

Primorigen Biosciences' mission is to develop robust, reliable reagents and tools in support of research and clinical applications of stem cells. These include StemAdhere™ and StemAdhere XF™, a defined and/ or xenobiotic-free substrate for the maintenance and expansion of pluripotent cells.

Events